SECURKLOUDNSE30 June 2021

SECUREKLOUD TECHNOLOGIES LIMITED has informed the Exchange about Investor Presentation

SECUREKLOUD TECHNOLOGIES LIMITED

Ref: SK/CHN/2021-22/E010

June 30, 2021

National Stock Exchange of India Ltd. Capital, Market – Listing, Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra‐Kurla Complex, Bandra (E), Mumbai 400 051. EQ- SECURKLOUD– ISIN NO- INE650K01021

BSE Ltd, 25th Floor, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai 400 001. Scrip Code: 512161 - ISIN NO-INE650K01021

Dear Sir/Madam,

Sub: Intimation of the outcome of the Board Meeting under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations").

In terms of Regulation 30 read with Schedule III of the Listing Regulations, we hereby inform you that at the meeting of the Board of Directors ("Board") of SecureKloud Technologies Limited (Formerly 8K Miles Software Services Limited) ("Company") held today, i.e., Wednesday, June 30, 2021, the Board has approved, inter alia, the following:

1. Audited financial results:

Audited financial results (Standalone and Consolidated) for the quarter and year ended March 31, 2021. In this regard, we enclose copies of the following as prescribed under Regulation 33 of the Listing Regulations:

• The detailed format of the audited financial results (standalone and consolidated) being submitted as per the listing regulations. The said results will be uploaded on the websites of the Company. The financial results will also be published as per the format prescribed in the listing regulations.

• Auditors Report from the statutory auditors, M/s. K. Gopal Rao & Co., Chartered Accountants, for the financial results (standalone and consolidated) for the quarter and year ended March 31, 2021.

• Declaration under Regulation 33(3)(d) of the Listing Regulations in respect of unmodified opinion on Audited Financial Statements for the Financial Year ended March 31, 2021.

• Press release about the above financial results being released for publication. • Earnings call presentation.

2. Convening of Annual general meeting (AGM):

Convening of 36th AGM of the Company on Thursday, the September 30, 2021. The Register of Members will be closed from Sunday, September 26, 2021 to Thursday, September 30, 2021 (both days inclusive) for the purpose of Annual General.

3. Dissolution of CSR Committee:

Pursuant to Companies (CSR Policy) Amendment Rules, 2021 W.e.f 22/01/2021, CSR Committee not required, if amount to be spent by a company does not exceed fifty lakh rupees. Further to that, Board considered and dissolved the Committee since the amount required to be spent is less than the specified limit.

The Board meeting commenced at 9.15 A.M and concluded at 10.45 A.M

We request you to kindly take the above information on record.

Yours Truly, For SecureKloud Technologies Limited

G Sri Vignesh Company Secretary and Compliance Officer Membership No: A57475

FY21 Q4 Earnings Presentation

June 30, 2021

Safe Harbor Notice

This presentation has been prepared by SecureKloud Technologies Ltd. solely to provide information about the Company.

No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. None of the Company nor any of its respective affiliates, advisers or representatives, shall have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection with this presentation.

The information contained in this presentation is only current as of its date. The Company may alter, modify or otherwise change in any manner the content of this presentation, without obligation to notify any person of such revision or changes. Certain statements made in this presentation may not be based on historical information or facts and may be "forward-looking statements", including those relating to the Company’s general business plans and strategy, its future financial condition and growth prospects, and future developments in its industry and its competitive and regulatory environment. Actual results may differ materially from these forward- looking statements due to a number of factors, including future changes or developments in the Company’s business, its competitive environment, information technology and political, economic, legal and social conditions in India. Please note that this presentation is based on the publicly available information on SecureKloud Technologies Ltd. including but not limited to Company’s website and Annual Reports.

This communication is for general information purposes only, without regard to specific objectives, financial situations and needs of any person. Please note that investments in securities are subject to risks including loss of principal amount. This presentation does not constitute an offer or invitation to purchase or subscribe for any shares in the Company and neither any part of it shall form the basis of or be relied upon in connection with any contract or commitment whatsoever.

Business Update

“We have been successful in penetrating healthcare providers market during the fiscal year 2021 by winning many new customers who are adopting our cloud managed services, healthcare AI and cloud backup/DR solutions in addition to EHR implementation and interoperability service offerings. We have also deepened our relationships with our existing Life Sciences customers and business partners including AWS and Google Cloud – a significant is not very achievement given the business sentiment upbeat across the world due to Covid-19. All our existing yearly contracts have been renewed clearly demonstrating our leadership position in the marketplace.

Our increased investment in Sales and Marketing, Research and Development in SaaS platforms have positioned us uniquely for accelerated revenue growth and we are confident that we can expect double digit growth in FY 22.”

- Suresh Venkatachari, Chairman & CEO

Company Overview

SecureKloud, a market leader in Enterprise Cloud Transformation for highly regulated industries that have stringent Cloud Security & Compliance requirements.

Location

Industry Verticals

• HQ: Chennai, India • US HQ: Pleasanton, CA • Sales Office: Chicago, IL; East Brunswick, NJ;

Pleasanton, CA

• DevOps Centers: Pleasanton, CA and Chennai, India

• Healthcare & Life Sciences • Automotive • BFSI • Media & Entertainment • Manufacturing & Supply chain

Partnerships

Offerings

• AWS Premier Partner – 6 years in a row • 4th consecutive year - Audited AWS managed services

provider

• Google Cloud Services partner with top 8 healthcare

interoperability provider status

• Extensive knowledge and expertise in Microsoft

• Platforms: CloudEz, DataEz, Readabl.AI, CloudAuth,

Blockedge

• Cloud and DevOps Automation • Nextgen Managed Services • Data Science, Analytics and AI/ML Services • Cloud Security and Compliance

Azure

Our Cloud Expertise

• Multi cloud automation

expertise – AWS, Azure & GCP

• First to market SaaS based

CloudEz, DataEz and Readabl.AI platforms for industry verticals

• Enterprise-wide business transformation services

• Industry recognized

innovative Cloud and AI solutions

Cloud Competency Centre

Migration

Security, Compliance

Managed Services

Competencies across multiple domains

Security

Operations Compliance

Security & Regulatory Compliance

•

Regulatory Compliance Experts ✓ HIPAA, GxP, FIPS, PCI-DSS, etc.

Battle Tested at Highly Regulated Industries

Chaired & contributed to SAML 2.0 Specification

HITRUST Certification – self assessed, pending 3rd party certification

ISO 27001:2013 recertification achieved

FY21 Q4 Earnings

Business Highlights

Growth in Healthcare and Life Sciences

• Added a new customer for Readabl.ai, our flagship Healthcare AI product

• Added three new customers for providing MEDITECH Technical services

• Closed multiple customer contracts to provide MEDITECH/EPIC related technical

services and post live Managed Services

• Partnership signed to provide private cloud hosting production and cloud DR

solution to our Meditech customers

• Renewed yearly Cloud and DevOps support for several Life Sciences customers

• Renewed our contract with a Global Fortune 500 Life Sciences customer for delivering Cloud and Data Analytics services through CloudEz and DataEz platforms

Growth in Other Industries

• Signed a multi-year contract with a leading Identity and Access Management

vendor to build and manage identity provisioning capabilities for large enterprise applications and cloud providers

• Signed a new cloud transformation project with one of our large existing

customers

• Signed a new project for one of our existing customers for developing their Data

Platform on AWS

• Signed GNOE acceleration project with one of our existing customers • Renewed all our enterprise customers in Automotive, AI and Industry technology

areas

• Secured multiyear Managed Services contract signed with our key customers

Recognitions

New Launches

Launched Readabl.ai – a SaaS-based, AI- powered Healthcare Document Workflow

Google Cloud highlighted HTI as a key partner for Healthcare Interoperability

Launched CloudEz – a Hybrid Cloud Management Platform as a SaaS Service on Marketplaces

FY21 Q4 Earnings

Financial Highlights

Consolidated Financial Highlights (₹ in lakhs)

• Revenue growth of 21.5 % in Q4FY21 compared to Q4FY20

• Q4FY21 EBITDA Rs 317 Lakhs compared to Rs (2,009) Lakhs in Q4FY20

• EBITDA margin at 3.8% in Q4FY21 compared to (29.4%) in Q4FY20

• FY 20 numbers for Q4 and full year have been normalized for one time impact

Key IndicatorsQ4 FY21Q4 FY20YoYFY 21FY 20 YoYRevenueRevenue from Operation8,293 6,823 21.5%35,055 38,208 -8.3%ExpensesEmployee Benefit Expenses4,782 4,238 -11.4%19,158 25,499 33.1%Other Operating Expenses3,194 4,595 43.8%12,600 15,292 21.4%Total Expenditure7,976 8,832 10.7%31,757 40,791 28.4%EBITDA317 (2,009) 115.8%3,297 (2,582) 227.7%EBITDA margin3.8%-29.4%9.4%-6.8%Other Income(18) 271 -106.7%(94) 435 -121.6%Depreciation and Amortisation177 489 63.8%1,850 1,957 5.8%Finance Cost290 390 25.5%1,200 1,303 8.5%PBT(169) (2,618) 106.4%153 (5,407) 97.2%Tax(17) (211) 91.7%35 279 PAT(151) (2,406) 106.3%118 (5,687) 97.9%Q4 Snapshot (₹ in lakhs)

Revenue

8,293

Gross Profits

2,628 (31.7%)

EBITDA

317 (3.8%)

Recurring Revenue

35.2%

FY 21: Revenue and EBITDA (₹ in lakhs)

Revenue Q4 FY21

8,293

6,823

EBITDA Q4 FY21

317

Q4 FY20

Q4 FY21

Q4 FY20

Q4 FY21

(2,009)

Revenue FY21

38,208

35,055

EBITDA FY21

3,297

FY 20

FY 21

FY 20

FY 21

Quarter Financials (₹ in lakhs)

Revenue

Recurring revenue

8,807

8,904

9,051

8,293

34.7%

35.2%

34.0%

32.5%

Q1 FY 21

Q2 FY 21

Q3 FY 21

Q4 FY 21

Q1 FY 21

Q2 FY 21

Q3 FY 21

Q4 FY 21

R & D Expenses and % to revenue

8.4% 742

6.5%

579

8.4% 760

8.5%

702

Q1 FY 21

Q2 FY 21

Q3 FY 21

Q4 FY 21

Revenue Metrics

Overall recurring revenue has gone up to 35.2% in Q4 FY 21 from 34.7% in Q3 FY 21

Life Science

Healthcare

ICT

Recurring

Non-Recurring

55.7%

58.0%

67.5%

66.0%

65.3%

64.8%

49.8%

47.1%

27.8%

25.7%

16.5%

16.3%

31.6%

31.1%

32.5%

34.0%

34.7%

35.2%

18.7%

21.8%

Q1 FY 21

Q2 FY 21

Q3 FY 21

Q4 FY 21

Q1 FY 21

Q2 FY 21

Q3 FY 21

Q4 FY 21

Segmental Revenue

Recurring / Non-Recurring Revenue

Top 10 customers

Revenue contribution from top 10 customers came down from 74% in Q3 FY 21 to 70.4% in Q4 FY 21.

73.2%

74.9%

74.0%

70.3%

Client Composition and Relationship

Q1 FY 21

Q2 FY 21

Q3 FY 21

Q4 FY 21

Head count metrics

• Added 32 resources in Q4 • Invested in 18 additional

S&M resources during the financial year • 12 of them were added in Q4 FY21 in the US and India to accelerate new customer acquisitions • Ramped up support staff in

India

• Head count includes full time and contractors

Head Count

(Incl. Contractors)

Software Professional

S&M

G&A

Q1 FY 21 Q2 FY 21 Q3 FY 21 Q4 FY 21

417

425

432

447

Total

503

514

520

552

Women employees represent 23% of total headcounts

Statement of Audited Consolidated Financial Results (₹ in lakhs)

31 Mar 202131 Dec 202031 Mar 202031 Mar 202131 Mar 2020 Audited Un-audited Audited Audited Audited Income a) Revenue from operations8,2939,0516,82335,05538,208b) Other income(18)(37)271(94)435Total income8,2759,0147,09434,96138,643Expensesa) Employee benefits expense4,7824,5973,75319,15825,015b) Finance costs2902873901,2001,303c) Depreciation and amortization expense177588(2,140)1,8502,157d) Other expenses3,1943,0805,35012,60016,047Total expenses8,4448,5527,35334,80744,522Profit before exceptional items and tax (169)462(259)153(5,878)Exceptional items0013,761061,294Profit before tax(169)462(14,020)153(67,172)Tax expense- Current tax(42)(45)(312)270- Deferred tax24(8)1008279Net profit after tax for the period (151)516(13,809)118(67,451)Total comprehensive income for the period (154)516(13,803)112(69,996)Total comprehensive income attributable to:Owners of the company(116)238(12,883)154(52,723)Non-controlling Interest(38)277(920)(41)(17,273)Paid-up equity share capital (Face value of Rs. 5/- each]1,525.88 1,525.88 1,525.88 1,525.88 1,525.88 Number of equity shares30,517,605 30,517,605 30,517,605 30,517,605 30,517,605 Weighted average number of equity shares30,702,537 30,517,605 30,517,605 30,702,537 30,517,605 Reserves (Other Equity) - excluding any revaluation reserve2,571.42 1,243.32 Earnings per equity share (EPS) [Face value of Rs. 5/- each] (a) Basic (Rs.)(0.37) 0.78 (42.23) 0.52 (164.42) (b) Diluted (Rs.)(0.37) 0.78 (42.23) 0.52 (164.42) Quarter EndedYear EndedParticularsAudited Consolidated Balance Sheet (₹ in lakhs)

Particulars As at31 Mar 2021 As at31 Mar 2020 Shareholder's Funds4,097 2,769 Borrowings13,998 11,758 Trade Payables3,697 5,338 Other Liabilities4,976 4,061 Total Liabilities26,767 23,925 Fixed Assets 224 470 Goodwill 12,827 13,830 Intangible Assets2,894 3,500 Trade Receivables5,515 5,057 Cash, Bank & Investments3,448 793 Other Assets1,858 275 Total Assets26,767 23,925 Audited Consolidated Cash Flow Statement (₹ in lakhs)

Particulars 31 Mar 2021 31 Mar 2020 I. Cash flow from operating activities(Loss) / Profit for the year118(67,451)Adjustments for:Income tax expense recognised in the statement of profit and loss35279Finance cost recognised in statement of profit and loss1,2001,303Exceptional Item - Impairment of Assets052,573Depreciation and amortisation Expense1,8502,157Net loss/ (gain) on Sale of Property, Plant and Equipment (Net)0103Bad Receivables Written off01,674Net Unrealised Exchange Gain(118)(225)Operating (loss) / profit before working capital and other changes3,086(9,588)Adjustments for (increase)/decrease in operating assets:Trade Receivables(459)12,068Other Non Current Financial Assets1(29)Other Non Current Assets(51)(20)Other Current Financial Assets(924)1,707Other Current Assets(270)5,265Adjustments for increase/(decrease) in operating liabilities:Trade Payables(1,641)(2,984)Other Non Current Liabilities(4)0Provisions (Non-current)345Provisions (Current)(17)1Other Current Financial Liabilities558(844)Other Current Liabilities3701,483Cash generated from operations6827,063Net Income Tax paid (including interest paid there on)(338)(186)Net cash flow from operating activities (A)3446,878II. Cash flow from investing activities(29)(29)Proceeds from Sale of Property, Plant and Equipment70Net cash flow used in investing activities (B)(22)(29)III. Cash flow from financing activities1,1250Borrowings taken during the year3,4211,473Borrowings repaid during the year(1,180)(492)Finance Costs(1,200)(1,303)Net cash flow from financing activities (C)2,165(321)Effect of foreign currency translation adjustment (D)168(6,550)2,655(22)7938153,448793Cash and cash equivalents at the end of the year Capital Expenditure on Property, Plant and Equipment Proceeds from issue of Equity Shares (including premium / Share application money) Net (Decrease) in Cash and Cash Equivalents (A) + (B) + (C) + (D)Cash and cash equivalents at the beginning of the year Net DEBT Status (₹ in lakhs)

• The Net Debt position of the Company has come down from Rs

10,964 Lakhs in Mar 20 to Rs 10,549 lakhs in Mar 21

• Convertible Note of Rs 3,109 Lakhs will convert to equity on listing of

Healthcare Triangle Inc, US

TypeAs on Mar 20As on Sep 20As on Mar 21Loan from Banks5,489 5,370 5,599 Promoters6,269 6,500 5,289 Convertible - Note- - 3,109 Gross Debt11,758 11,870 13,997 Cash in Hand 793 672 3,448 Net Debt10,964 11,198 10,549 OUTLOOK FOR FY22

Witnessing growth in Life Sciences and Healthcare business recovery post second wave of the pandemic

• Focusing on growing the

recurring revenues

• Expecting accelerated growth

in revenue in FY 22

Continued investment in Sales & Marketing, R&D and SaaS platforms have positioned us uniquely for accelerated revenue growth

• Expecting with confidence, a double-digit growth in FY 22

Thank You

← All Transcripts SECURKLOUD Stock Page →

SECUREKLOUD TECHNOLOGIES LIMITED has informed the Exchange about Investor Presentation

Market Movers